glp-1 receptor agonist news agonists show promise in treating substance use disorders Many patients taking glucagon-like peptide-1

Some peptide makers are public companies or are part of larger drug and chemical firms

Adults (18+): Take 1 capsule, 12 times daily between meals

Once youve been assessed and approved by our medical provider, you are committed to either a 6-month plan, and early cancellations or refunds are not available

When a product relies on fake social proof rather than real clinical data, it raises serious questions about legitimacy

This can lead to higher metabolism and more efficient fat burning

This blog, based on IQVIAs 18th March 2026 webinar on the future of the Obesity Medicines market, looks ahead to the next phase of that transformation, examining how the obesity market evolves from 2026 to 2030, and how the drivers of success shift from rapid adoption to differentiation, longterm performance and systemlevel impact